STAAR Surgical Company (STAA)

Operating return on assets (Operating ROA)

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Operating income US$ in thousands 28,097 43,802 33,339 6,769 11,852
Total assets US$ in thousands 488,692 418,818 345,778 257,416 207,523
Operating ROA 5.75% 10.46% 9.64% 2.63% 5.71%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $28,097K ÷ $488,692K
= 5.75%

STAAR Surgical Company's operating return on assets (operating ROA) has shown fluctuations over the past five years. In 2023, the operating ROA decreased to 5.75% from 10.46% in 2022, indicating a decline in the company's operating efficiency in generating profit from its assets. Although the 2023 operating ROA is lower than in 2022, it is still above the 5-year average.

Comparing 2023 to 2021, the operating ROA decreased from 9.64% to 5.75%, suggesting a significant drop in operating performance. However, it is important to note that the 2023 operating ROA is higher than in 2020 when it was 2.63%. This improvement over the 2020 performance indicates a recovery in the company's ability to generate profits from its assets.

In comparison to 2019, the operating ROA in 2023 decreased slightly from 5.71% to 5.75%. This marginal decline suggests relative stability year-over-year in the company's operational efficiency in utilizing its assets to generate earnings.

Overall, while STAAR Surgical Company's operating ROA experienced fluctuations over the past five years, the 2023 performance indicates a moderate decline compared to the previous year but remains relatively stable compared to the 5-year historical average. Further analysis of the company's operating efficiency and asset management practices may be required to understand the factors influencing these changes in operating ROA.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
STAAR Surgical Company
STAA
5.75%
National Vision Holdings Inc
EYE
-2.16%
The Cooper Companies, Inc. Common Stock
COO
5.73%